
Rubius Therapeutics, a biotech that has ambitions to bring “super blood” to the market, has revealed that it has appointed …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

